William Abraham

Professor of Medicine, Physiology, and Cell Biology at the Ohio State University

William T. Abraham, MD, is the Chief Medical Officer at V-Wave Ltd., a medtech company focused on developing innovative therapies for heart failure. He joined V-Wave in 2019 after more than 16 years as the Director of the Division of Cardiovascular Medicine at The Ohio State University. Initially, he served as Chairman of the Strategic Advisory Board at V-Wave before taking on the CMO role full-time in 2019.1 2

Education and Career Background

Medical Degree: Harvard Medical School
Residency: Internal Medicine
Fellowships: Cardiology and heart failure/cardiac transplantation at the University of Colorado Health Sciences Center.

Dr. Abraham is a distinguished clinician and researcher, recognized as one of the "Best Doctors in America" for 18 consecutive years. His research primarily focuses on heart failure, including hemodynamic and neurohormonal mechanisms, and he has been involved in significant clinical trials that have shaped current treatment standards.1 2 3

Contributions and Leadership

At V-Wave, Dr. Abraham leads the Medical Affairs department and plays a crucial role in clinical programs, including pivotal studies like RELIEVE-HF. His extensive experience includes participation as a principal investigator in over 100 multicenter clinical trials, contributing to the development of new therapies for heart failure.2 3

Dr. Abraham maintains his academic position as a Professor of Internal Medicine, Physiology, and Cell Biology at The Ohio State University while focusing on his role at V-Wave.1 4